Clinical outcomes of immune checkpoint inhibitors in HER2-amplified non-small cell lung cancers Meeting Abstract


Authors: DeMatteo, R.; Goldman, D. A.; Lin, S. T.; Buonocore, D. J.; Gao, J.; Chang, J. C.; Rekhtman, N.; Offin, M.; Yu, H. A.; Isbell, J. M.; Jones, D. R.; Rudin, C. M.; Travis, W. D.; Kris, M. G.; Drilon, A. E.; Arcila, M. E.; Ginsberg, M. S.; Iasonos, A.; Liu, D. Z.; Li, B. T.
Abstract Title: Clinical outcomes of immune checkpoint inhibitors in HER2-amplified non-small cell lung cancers
Meeting Title: 2022 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 40
Issue: 16 Suppl.
Meeting Dates: 2022 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2022-06-01
Language: English
ACCESSION: WOS:000863680304344
PROVIDER: wos
DOI: 10.1200/JCO.2022.40.16_suppl.e21098
Notes: Meeting Abstract: e21098 -- This meeting was also held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Natasha Rekhtman
    434 Rekhtman
  2. Michelle S Ginsberg
    238 Ginsberg
  3. Helena Alexandra Yu
    289 Yu
  4. Alexia Elia Iasonos
    365 Iasonos
  5. William D Travis
    750 Travis
  6. Maria Eugenia Arcila
    669 Arcila
  7. Mark Kris
    872 Kris
  8. Alexander Edward Drilon
    636 Drilon
  9. Jianjiong Gao
    132 Gao
  10. Debra Alyssa Goldman
    158 Goldman
  11. Charles Rudin
    495 Rudin
  12. David Randolph Jones
    421 Jones
  13. Jason Chih-Peng Chang
    142 Chang
  14. Bob Tingkan Li
    279 Li
  15. Dazhi   Liu
    45 Liu
  16. James Michael Isbell
    128 Isbell
  17. Michael David Offin
    173 Offin
  18. Sabrina Lin
    25 Lin